Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2CNS 2Tumor-Agnostic 1Sarcoma 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 101Specimen Handling 83pembrolizumab 76enzalutamide 63Nivolumab 59Gemcitabine 56Docetaxel 50apalutamide 42Radiosurgery 42Abiraterone Acetate 40Prednisone 39Androgen Antagonists 39Cisplatin 37Biopsy 37darolutamide 36cabozantinib 32Radiotherapy 32Pluvicto 28Carboplatin 28abiraterone 27Ipilimumab 25enfortumab vedotin 24durvalumab 24Radiation 23atezolizumab 22X-Rays 21Leuprolide 20Standard of Care 19olaparib 18avelumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Protons × Genitourinary × 90 days × Clear all
NCT04190446 2026-06-04

A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

Mayo Clinic

Phase 2 Active not recruiting
84 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡